Development of a Phase Transfer Catalyzed Asymmetric Synthesis for an Estrogen Receptor Beta Selective Agonist
详细信息 查看全文
- 作者：Jeremy P. Scott ; Michael S. Ashwood ; Karel M. J. Brands ; Sarah E. Brewer ; Cameron J. Cowden ; Ulf-H. Dolling ; Khateeta M. Emerson ; Andrew D. Gibb ; Adrian Goodyear ; Steven F. Oliver ; Gavin W. Stewart ; De
- 刊名：Organic Process Research & Development
- 出版年：2008
- 出版时间：July 2008
- 年：2008
- 卷：12
- 期：4
- 页码：723-730
- 全文大小：191K
- 年卷期：v.12,no.4(July 2008)
- ISSN：1520-586X
文摘
A practical asymmetric synthesis of the estrogen receptor beta selective agonist (7β-9aβ)-1,4-dichloro-2-hydroxygibba-1(10a),2,4,4b-tetraen-6-one (1), proceeding by way of six isolated intermediates and without recourse to chromatography, is described. Highlights of the process route developed are two chemoselective chlorinations, a lithiated hydrazone alkylation and an asymmetric Michael addition of indanone 11 to methyl vinyl ketone (using 15 mol % of cinchonine-derived catalyst 20g) to set the all-carbon quaternary asymmetric stereocenter. The challenges addressed in scaling the latter heterogeneous biphasic phase transfer reaction to 44 mol (14 kg) scale are discussed in detail. Overall, the chemistry developed has been used to prepare >6 kg of drug candidate 1 in 18% overall yield and with >99% ee.